TARO
Taro Pharmaceutical Industries Ltd.TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
About: Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Employees: 1,554
Financial journalist opinion
Neutral
Accesswire
6 months ago
FINAL REMINDER TARO DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Taro Pharmaceutical Industries Ltd. Investors to Participate in the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / November 12, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. ("Taro" or "the Company") (NYSE:TARO) and certain of its officers.
Neutral
Accesswire
6 months ago
FINAL TARO DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Taro Pharmaceutical Industries Ltd. Investors to Join the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / November 11, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. ("Taro" or "the Company") (NYSE:TARO) and certain of its officers.
Neutral
GlobeNewsWire
6 months ago
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Nov. 10, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. (“Taro” or “the Company”) (NYSE: TARO) and certain of its officers.
Neutral
Accesswire
6 months ago
TARO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Taro Pharmaceutical Industries Ltd. to Contact the Firm Today!
NEW YORK, NY / ACCESSWIRE / November 10, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. ("Taro" or "the Company") (NYSE:TARO) and certain of its officers.
Neutral
Accesswire
6 months ago
TARO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Taro Pharmaceutical Industries Ltd. to Contact the Firm Today!
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. ("Taro" or "the Company") (NYSE:TARO) and certain of its officers.
Neutral
Accesswire
6 months ago
TARO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Taro Pharmaceutical Industries Ltd. to Contact the Firm Today!
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. ("Taro" or "the Company") (NYSE:TARO) and certain of its officers.
Neutral
Accesswire
7 months ago
TARO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Taro Pharmaceutical Industries Ltd. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / November 6, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. ("Taro" or "the Company") (NYSE:TARO) and certain of its officers.
Neutral
Accesswire
7 months ago
TARO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Taro Pharmaceutical Industries Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / November 5, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. ("Taro" or "the Company") (NYSE:TARO) and certain of its officers.
Neutral
GlobeNewsWire
7 months ago
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. (“Taro” or “the Company”) (NYSE: TARO) and certain of its officers.
Neutral
Accesswire
7 months ago
TARO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Taro Pharmaceutical Industries Ltd. Stockholders Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. ("Taro" or "the Company") (NYSE:TARO) and certain of its officers.
Charts implemented using Lightweight Charts™